esophagus, liver, prostate
Regulatory status: IVD, FDA Class I
60-0025-7 7mL RTU
61-0025 1mL concentrate
This antibody is useful for differentiating benign prostate gland from prostate adenocarcinoma when used in a panel of antibodies. Monoclonal antibody clone 34bE12 can be used for the demonstration of high molecular weight cytokeratinin the basal cells of prostate specimens, but due to cross-reaction to low molecular weight cytokeratin in e.g. breast epithelial cells/breast carcinoma it cannot be recommended as a general marker for high molecular weight cytokeratin. This is a useful tool when used in a panel of antibodies.